fig2

Mechanisms of resistance to antibody-drug conjugates in cancer therapy: molecular basis and therapeutic strategies

Figure 2. Main mechanisms of resistance to ADC drugs. Resistance to ADCs arises through multiple mechanisms that impair their efficacy at various stages. The main mechanisms include the antigen-related resistance, payload resistance, antibody component resistance, intracellular trafficking defects, linker instability and drug release issues, as well as alterations in signaling pathways. Created in BioRender. Hao, Y. (2025) https://BioRender.com/2b91iun. ADC: Antibody-drug conjugate; PI3K: phosphoinositide 3-kinase; AKT: AKT serine/threonine kinase; mTOR: mechanistic target of rapamycin; PTEN: phosphatase and tensin homolog.

Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/